Big Gain For Armata Pharmaceuticals Inc.

Tue, Jul 25, 2023 at 07:27 PM

Armata Pharmaceuticals Inc. (ARMP:NYSEMKT) jumped higher at $1.97, representing a gain of 25.5%. On Tue, Jul 25, 2023, ARMP:NYSEMKT touched a New 2-Week High of $1.97. From Tue, Jul 11, 2023, the stock recorded 60.00% Up Days and 27.27% Green Days

About Armata Pharmaceuticals Inc. (ARMP:NYSEMKT)

Ampliphi Biosciences Corp is a clinical-stage biotechnology company focused on the development of bacteriophage-based therapies for the treatment of antibiotic-resistant bacterial infections. The company is developing phage product candidates using a proprietary discovery and development platform, which is designed for rapid identification, characterization, and manufacturing of multiple phage therapeutics. The lead product candidates are AB-SA01 for the treatment of Staphylococcus aureus infections; and AB-PA01 for the treatment of Paeruginosa infections.

Top 10 Gainers:

Aurora Acquisition Corp. (AURC:NASDAQ), 220.86%
Inpixon (INPX:NASDAQ), 89.49%
Electra Battery Materials Corporation (ELBM:NASDAQ), 70.73%
Colombier Acquisition Corp. Class A (CLBR:NYSE), 54.51%
Bullfrog AI Holdings Inc. (BFRG:NASDAQ), 44.22%
Yoshiharu Global Co. (YOSH:NASDAQ), 41.23%
Signature Bank (SBNY:NASDAQ), 34%
Galecto Inc. (GLTO:NASDAQ), 31.47%
Kiniksa Pharmaceuticals, Ltd. (KNSA:NASDAQ), 30.39%
Armata Pharmaceuticals Inc. (ARMP:NYSEMKT), 25.48%